IMRIS announced that its horseshoe headrest has been selected one of 10 New Technology Showcase Winners by Twin Cities-based Life Sciences Alley (LSA), the USA’s largest regional medical industry association. The first MR-safe and CT-compatible horseshoe headrest was introduced in February and will be among the products featured at the LSA Health Technology Leadership Conference on 19 November in Minneapolis, USA.
“Our products are the result of a core competency in designing patient-centred intraoperative imaging solutions. Leading paediatric neurosurgeons provided strong insights for developing this product and now those who have adopted it are serving a patient population not previously treated in the VISIUS Surgical Theatre for anticipated improved outcomes,” says Jay D Miller, IMRIS president and chief executive officer. “We look forward to sharing our headrest and other intraoperative imaging solutions with international industry professionals at the LSA conference.”
For procedures within the VISIUS Surgical Theatre, the horseshoe headrest provides non-pinned patient head support in prone, lateral, and supine positions during head, neck and cervical spine surgeries where use of a head fixation device – a clamp-like device – is not desirable because the skull is too fragile for pinning. These patients may be babies whose skulls are still soft or older patients with weakened skull bones.
The headrest also was specially designed for use with the new IMRIS InSitu wireless coil, a sterile, wireless, ultra-lightweight, and disposable imaging coil that eliminates the need to manage cables and heavy imaging coils typically draped and removed between intraoperative scans.
Inside a VISIUS Surgical Theatre equipped with either high-field intraoperative MRI (iMRI) or 64-slice intraoperative Computed Tomography (iCT), surgeons have on-demand access to real-time diagnostic quality imaging during the procedure and from the operating room table as the scanner uniquely moves to the patient on ceiling-mounted rails. VISIUS iMRI provides neurosurgeons the ability to assess and decide to perform further resection for removing as much tumour as possible by clearly visualising tumour and healthy brain tissue which otherwise are hard to differentiate.